• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number UNK-CV-SR-VALIANT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Stroke/CVA (1770); Infarction, Cerebral (1771); Fistula (1862); Hematoma (1884); Hemoptysis (1887); Hemorrhage, Cerebral (1889); Hemothorax (1896); Idioventricular Rhythm (1923); Unspecified Infection (1930); Ischemia (1942); Occlusion (1984); Pleural Effusion (2010); Pulmonary Insufficiency (2022); Renal Failure (2041); Rupture (2208); Perforation of Esophagus (2399); Respiratory Tract Infection (2420); Decreased Respiratory Rate (2485); Low Cardiac Output (2501); Vascular System (Circulation), Impaired (2572); Pseudoaneurysm (2605); Pericardial Effusion (3271)
Event Date 06/12/2018
Event Type  Injury  
Manufacturer Narrative
Medtronic received the following information from the journal article entitled; urgent endovascular treatment for non-traumatic descending thoracic aortic rupture rohit philip thomas, sandeep sunder amin, osama eldergash, tobias kowald, sebastian bremer, jerry easo, alexander weymann, malte book, marcin szczechowicz, bernhard schmuck and ajay chavan cardiovasc intervent radiol (2018) 41:1318¿1323, doi.Org/10.1007/s00270-018-2006-0.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Valiant stent graft systems were implanted in patients for the endovascular treatment of non traumatic rupture of the descending thoracic aorta due to type b dissections or atherosclerotic aortic aneurysms.No additional clinical sequelae were reported and the cause of the events is unknown.It was reported that on an unknown date the following events were recorded: serious injury; infection, stroke, tracheostomy ,rupture aneurysm, aneurysm enlargement, false lumen rupture, hemodynamic instability/ hemodynamic shock, circulatory collapse, hemothorax, respiratory insufficiency, oesophageal perforation, pulmonary infection, cardiac instability, hematomas, left subclavian artery coverage, hemorrhagic pericardial effusion, hemorrhagic pleural effusion, hemoptysis secondary to aorto-bronchial fistula, pseudoaneurysm, infarction,.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key7818442
MDR Text Key118290254
Report Number2953200-2018-01224
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-SR-VALIANT
Device Catalogue NumberUNK-CV-SR-VALIANT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/20/2018
Initial Date FDA Received08/27/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-